Ortho Clinical Diagnostics Announces Launch of Initial Public Offering
RARITAN, N.J., Jan. 19, 2021 /PRNewswire/ Ortho Clinical Diagnostics Holdings plc ( Ortho ), the world s largest pure-play in vitro diagnostics company dedicated to improving and saving lives through innovative laboratory testing and blood-typing solutions, today announced the launch of its initial public offering of its ordinary shares. Ortho is offering 70 million ordinary shares, with the initial public offering price expected to be between $20.00 and $23.00 per share.
Ortho expects to grant the underwriters a 30-day option to purchase up to 10.5 million additional ordinary shares at the initial public offering price less underwriting discounts and commissions. Ortho has applied to have its ordinary shares approved for listing on The NASDAQ Stock Market under the symbol OCDX.